Journals / Viral Hepatitis Journal / 2020 / Cilt: 26 - Sayı: 2

The Impact of COVID-19 Pandemic on Treatment, Followup and Behavioral Characteristics of Chronic Viral Hepatitis Patients

COVİD-19 Pandemisinin Kronik Viral Hepatit Hastalarının Tedavisi, Takibi ve Davranış Özellikleri Üzerindeki Etkisi

Pages
98–103
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The vast majority ofCVH patients paid attention to prevention measures for COVID-19.Conclusion: We can say that CVH patients’ awareness aboutCOVID-19 and application of control measures were well enough.Continuity of treatment can be provided in patients with chronicillness during crisis period with informing patients in a way not tocause anxiety and efficient implementations in healthcare system.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: It has been not yet fully understood whether chronicliver diseases may be considered as risk factors for critical course ofCoronavirus disease-2019 (COVID-19).
📊
Key Findings & Data:Considering the importanceof managing with COVID-19, we aimed to investigate the impactof the COVID-19 pandemic on treatment, follow-up and behavioralcharacteristics of chronic viral hepatitis (CVH) patients.Materials and Methods: Patients followed-up in our clinic withdiagnosis of chronic hepatitis B or C were screened retrospectivelyand a total 213 adults included in the study.
💡
Conclusion & Impact:The vast majority ofCVH patients paid attention to prevention measures for COVID-19.Conclusion: We can say that CVH patients’ awareness aboutCOVID-19 and application of control measures were well enough.Continuity of treatment can be provided in patients with chronicillness during crisis period with informing patients in a way not tocause anxiety and efficient implementations in healthcare system.
🔬Design:Survey & Empirical Study
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters

Abstract

Objectives: It has been not yet fully understood whether chronicliver diseases may be considered as risk factors for critical course ofCoronavirus disease-2019 (COVID-19). Considering the importanceof managing with COVID-19, we aimed to investigate the impactof the COVID-19 pandemic on treatment, follow-up and behavioralcharacteristics of chronic viral hepatitis (CVH) patients.Materials and Methods: Patients followed-up in our clinic withdiagnosis of chronic hepatitis B or C were screened retrospectivelyand a total 213 adults included in the study. We performed atelephone survey with patients.Results: The mean age of participants was 49.9±13.4 years. Of theparticipants, 62% were male. Totally 75 (35.2%) patients disruptedtheir follow-up visits due to COVID-19 pandemic. The only risk factorfor disruption in follow-up was found as anxiety. The vast majority ofCVH patients paid attention to prevention measures for COVID-19.Conclusion: We can say that CVH patients’ awareness aboutCOVID-19 and application of control measures were well enough.Continuity of treatment can be provided in patients with chronicillness during crisis period with informing patients in a way not tocause anxiety and efficient implementations in healthcare system.

Özet

Amaç: Kronik karaciğer hastalıklarının Koronavirüs hastalığı-2019’un (COVİD-19) kritik seyri için bir risk faktörü olup olmadığı henüz net olarak anlaşılamamıştır. COVİD-19 ile mücadelenin önemi göz önünde bulundurularak, COVİD-19 pandemisinin KVH hastalarının tedavi, takip ve davranış özellikleri üzerindeki etkisinin araştırılması amaçlanmıştır. Gereç ve Yöntemler: Kronik hepatit B veya C tanıları ile kliniğimizde takip edilen hastalar retrospektif olarak taranmış ve toplam 213 erişkin hasta çalışmaya dahil edilmiştir. Hastalar ile telefon görüşmesi yapılarak anket gerçekleştirilmiştir. Bulgular: Hastaların ortalama yaşı 49,9±13,4’tür. Katılımcıların %62’si erkektir. COVİD-19 pandemisi nedeni ile toplam 75 (%35,2) hasta takip vizitlerini aksatmıştır. Takibin aksatılmasındaki tek risk faktörü anksiyete bulunmuştur. KVH hastalarının büyük çoğunluğu COVİD-19’a yönelik korunma önlemlerine dikkat etmektedir. Sonuç: KVH hastalarının COVİD-19 farkındalıklarının ve kontrol önlemlerine uyumlarının oldukça iyi olduğu görülmüştür. Kriz dönemlerinde anksiyeteye neden olmayacak şekilde hastaların bilgilendirilmesi ve sağlık bakım sisteminde etkili uygulamalar sayesinde kronik hastalığı olan kişilerin tedavilerinin devamlılığı sağlanabilir.

🔖

Cite This Article

SARICIOĞLU, E. M., KAYAASLAN, B., GÜNER, R. (2022). The Impact of COVID-19 Pandemic on Treatment, Followup and Behavioral Characteristics of Chronic Viral Hepatitis Patients. Viral Hepatitis Journal, Cilt: 26 - Sayı: 2, 98–103. https://ajindex.com/articles/646359

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Zhang Y, Ma ZF. Impact of the COVID-19 pandemic on mental health and quality of life among local residents in Liaoning Province, China: A cross-sectional study. International journal of environmental research and public health. 2020;17:2381
  2. Fu J, Kong J, Wang W, Wu M, Yao L, Wang Z, Jin J, Wun D, Yu X. The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China. Thrombosis Research. 2020;192:3-8 3. Cucinotta D, Vanelli M. WHO Declares COVID-19 a Pandemic. Acta Biomed. 2020;91:157-160
  3. Demirbilek Y, Pehlivantürk G, Özgüler ZÖ, Alp Meşe E. COVID-19 outbreak control, example of ministry of health of Turkey. Turk J Med Sci. 2020;50(Si-1):489-494
  4. T.C. BS. COVID-19 (SARS-CoV-2 ENFEKSİYONU) (Bilim Kurulu Çalışması) Genel Bilgiler, Epidemiyoloji ve Tanı: T.C. SAĞLIK BAKANLIĞI; 2020 [updated 01.06.2020. Available from: https:// covid19bilgi.saglik.gov.tr/depo/rehberler/covid-19-rehberi/COVID19_REHBERI_GENEL_BILGILER_EPIDEMIYOLOJI_VE_TANI.pdf
  5. Boettler T, Newsome PN, Mondelli MU, Maticic M, Cordero E, Cornberg M, Berg T. Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper. JHEP Rep. 2020;2:100113
  6. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei C, Hui DSC, Du B, Li L,. Zeng G, Yuen KY, Chen R, Tang C, Wang T, Chen P, Xiang J, Li S, Wang J, Liang Z, Peng Y, Wei L, Liu Y, Hu Y, Peng P, Wang J, Liu J, Chen Z, Li G, Zheng Z, Qiu S, Luo J, Ye C, Zhu S, Zhong N. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382:1708-1720
  7. Qi X, Wang J, Li X, Wang Z, Liu Y, Yang H, Xiaodan L, Shi J, Xiang H, Liu T, Kawada N, Maruyama H, Jiang Z, Wang F, Takehara T, Rockey DC, Sarin SK; COVID-Cirrhosis-CHESS Group. Clinical course of COVID-19 in patients with pre-existing decompensated cirrhosis: initial report from China. Hepatol Int. 2020:1-5
  8. Sockalingam S, Leung SE, Cassin SE. The Impact of COVID-19 on Bariatric Surgery: Re-Defining Psychosocial Care. Obesity. 2020
  9. Cheng SK, Wong C, Tsang J, Wong K. Psychological distress and negative appraisals in survivors of severe acute respiratory syndrome (SARS). Psychol Med. 2004;34:1187-1195
  10. Fiorino G, Allocca M, Furfaro F, Gilardi D, Zilli A, Radice S, Spinelli A, Danese S. Inflammatory bowel disease care in the COVID-19 pandemic era: the Humanitas, Milan, experience. J Crohns Colitis. 2020
  11. Wang C, Pan R, Wan X, Tan Y, Xu L, Ho CS, Ho RC. Imme